The NHS is "leading the world" and is currently on track to eliminate Hepatitis C in England by 2025 due a pioneering drug deal and a strong effort to find those at risk.
A five-year contract worth almost £1 billion to buy antiviral drugs for patients has seen deaths from Hepatitis C – including liver disease and cancer – fall by 35%, leading NHS England to be five years ahead of global targets which were set at 10 per cent.
Dedicated “Find And Treat” programmes have also been a factor in the drive to cut deaths caused by Hepatitis C, with vulnerable communities such as the homeless now being treated.
